Basic Information
ID: ALA4676711
Type: Functional
Description: Potentiation of anticancer activity against human CAPAN-1 cells harboring BRCA mutant xenografted in SCID/nude mouse assessed as tumor growth inhibition at 0.15 mg/kg, po bid for 12 days co-administered with TMZ measured up to 9 weeks post-drug administration
Format: BAO_0000218
Organism: Homo sapiens
Cell type: CAPAN-1
Target: CAPAN-1(ALA614536)
Document: ALA4673259
Potentiation of anticancer activity against human CAPAN-1 cells harboring BRCA mutant xenografted in SCID/nude mouse assessed as tumor growth inhibition at 0.15 mg/kg, po bid for 12 days co-administered with TMZ measured up to 9 weeks post-drug administration: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4676711
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 397.48 | 3.16 | 3.16 |